Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
5.13
-0.15 (-2.84%)
At close: Jul 14, 2026, 4:00 PM EDT
5.12
-0.01 (-0.19%)
After-hours: Jul 14, 2026, 7:56 PM EDT
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,034
Profits / Employee
-$1,614,459
Market Cap
5.56M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| AIM ImmunoTech | 21 |
| Genprex | 13 |
| Processa Pharmaceuticals | 12 |
| Purple Biotech | 10 |
| Adial Pharmaceuticals | 5 |
| Addex Therapeutics | 3 |
| Xenetic Biosciences | 2 |
SILO News
- 14 hours ago - Silo Pharma subsidiary QwikAgents joins AMD AI program - TheFly
- 14 hours ago - Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform - GlobeNewsWire
- 4 days ago - Silo Pharma prices $11.7M at-the-market offering at $6.45 per share - TheFly
- 4 days ago - Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 7 days ago - Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program - GlobeNewsWire
- 15 days ago - Silo Pharma engages Resyca to conduct a robustness study for SPC-15 delivery - TheFly
- 15 days ago - Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request - GlobeNewsWire
- 21 days ago - Silo Pharma reports positive stability data for stress treatment SPC-15 - TheFly